Mariya M. Kucherenko

Mariya M. Kucherenko

Auto-generated profile, based on publicly available information

Mariya M. Kucherenko

Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Physiology, Charitéplatz 1, Berlin, Germany

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2024 in Circulation
Verified
Journal Article
Closed access
QZQi Zhang
Qi Zhang
NYNobuhiro Yaoita
Nobuhiro Yaoita
ATArata Tabuchi
Arata Tabuchi
SLShaofei Liu
Shaofei Liu
SCShiau-Haln Chen
Shiau-Haln Chen
WKWolfgang Kuebler
Wolfgang Kuebler
BACKGROUND: Endothelial cell (EC) apoptosis and proliferation of apoptosis-resistant cells is a hallmark of pulmonary hypertension (PH). Yet, why some ECs die and others proliferate and how this contributes to vascular remodeling is unclear. We hypothesized that this differential response may: (1) relate to different EC subsets, namely pulmonary artery (PAECs) versus microvascular ECs (MVECs); (2) be attributable to autophagic activation in both EC subtypes; and (3) cause replacement of MVECs by PAECs with subsequent distal vessel muscularization. METHODS: EC subset responses to chronic hypoxia were assessed by single-cell RNA sequencing of murine lungs. Proliferative versus apoptotic responses, activation, and role of autophagy were assessed in human and rat PAECs and MVECs, and in precision-cut lung slices of wild-type mice or mice with endothelial deficiency in the autophagy-related gene 7 ( Atg7 EN-KO ). Abundance of PAECs versus MVECs in precapillary microvessels was assessed in lung tissue from patients with PH and animal models on the basis of structural or surface markers. RESULTS: In vitro and in vivo, PAECs proliferated in response to hypoxia, whereas MVECs underwent apoptosis. Single-cell RNA sequencing analyses support these findings in that hypoxia induced an antiapoptotic, proliferative phenotype in arterial ECs, whereas capillary ECs showed a propensity for cell death. These distinct responses were prevented in hypoxic Atg7 EN-KO mice or after ATG7 silencing, yet replicated by autophagy stimulation. In lung tissue from mice, rats, or patients with PH, the abundance of PAECs in precapillary arterioles was increased, and that of MVECs reduced relative to controls, indicating replacement of microvascular by macrovascular ECs. EC replacement was prevented by genetic or pharmacological inhibition of autophagy in vivo. Conditioned medium from hypoxic PAECs yet not MVECs promoted pulmonary artery smooth muscle cell proliferation and migration in a platelet-derived growth factor–dependent manner. Autophagy inhibition attenuated PH development and distal vessel muscularization in preclinical models. CONCLUSIONS: Autophagic activation by hypoxia induces in parallel PAEC proliferation and MVEC apoptosis. These differential responses cause a progressive replacement of MVECs by PAECs in precapillary pulmonary arterioles, thus providing a macrovascular context that in turn promotes pulmonary artery smooth muscle cell proliferation and migration, ultimately driving distal vessel muscularization and the development of PH.

14 November 2024 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
SLShao-Fei Liu
Shao-Fei Liu
MKMariya M. Kucherenko
Mariya M. Kucherenko
PSPengchao Sang
Pengchao Sang
QLQiuhua Li
Qiuhua Li
JYJuquan Yao
Juquan Yao
WKWolfgang Kuebler
Wolfgang Kuebler
Background: Calcification is common in chronic vascular disease, yet its role in pulmonary hypertension due to left heart disease is unknown. Here, we probed for the role of runt-related transcription factor-2 (RUNX2), a master transcription factor in osteogenesis, and its regulation by the HIPPO pathway transcriptional coactivator with PDZ-binding motif (TAZ) in the osteogenic reprogramming of pulmonary artery smooth muscle cells and vascular calcification in patients with pulmonary hypertension due to left heart disease. We similarly examined its role using an established rat model of pulmonary hypertension due to left heart disease induced by supracoronary aortic banding.Methods: Pulmonary artery samples were collected from patients and rats with pulmonary hypertension due to left heart disease. Genome-wide RNA sequencing was performed, and pulmonary artery calcification assessed. Osteogenic signallingviaTAZ and RUNX2 was delineated by protein biochemistry.In vivo, the therapeutic potential of RUNX2 or TAZ inhibition by CADD522 or verteporfin was tested in the rat model.Results: Gene ontology term analysis identified significant enrichment in ossification and osteoblast differentiation genes, includingRUNX2, in pulmonary arteries of patients and lungs of rats with pulmonary hypertension due to left heart disease. Pulmonary artery calcification was evident in both patients and rats. Both TAZ and RUNX2 were upregulated and activated in pulmonary artery smooth muscle cells of patients and rats. Co-immunoprecipitation revealed a direct interaction of RUNX2 with TAZ in pulmonary artery smooth muscle cells. TAZ inhibition or knockdown decreased RUNX2 abundance due to accelerated RUNX2 protein degradation rather than reducedde novosynthesis. Inhibition of either TAZ or RUNX2 attenuated pulmonary artery calcification, distal lung vascular remodelling and pulmonary hypertension development in the rat model.Conclusion: Pulmonary hypertension due to left heart disease is associated with pulmonary artery calcification that is driven by TAZ-dependent stabilisation of RUNX2, causing osteogenic reprogramming of pulmonary artery smooth muscle cells. The TAZ–RUNX2 axis may present a therapeutic target in pulmonary hypertension due to left heart disease.

3 December 2025 in Cardiovascular Research
Verified
Journal Article
Open access
NVNetra Nambiar Veetil
Netra Nambiar Veetil
TGTara Gransar
Tara Gransar
SLShao-Fei Liu
Shao-Fei Liu
AAAhed Almalla
Ahed Almalla
MKMarieluise Kirchner
Marieluise Kirchner
CKChristoph Knosalla
Christoph Knosalla
Aims: Hyperplasia of pulmonary arterial smooth muscle cells (SMCs) contributes to the progression of pulmonary hypertension (PH), yet the underlying pathomechanism of this process in PH secondary to left heart disease (PH-LHD) is poorly understood. We aimed to investigate the role of the endothelial extracellular matrix (ECM), specifically the pulmonary arterial basement membrane (BM), in influencing SMC proliferation and phenotypic changes in PH-LHD. Methods and results: SMC hyperplasia and endothelial ECM remodelling were characterized histologically on human pulmonary arterial samples, and by mass spectrometry, and atomic force microscopy on decellularized ECM (dECM) produced in vitro by endothelial cells isolated from pulmonary arteries (PA) of LHD patients without pulmonary hypertension (LHD w/o PH), PH-LHD patients, or healthy-heart controls. Proliferation and migration rates of SMC cultured on endothelial dECM were assessed by Ki67 immunostaining and by wound-healing assay, respectively. The role of mechanosensitive YAP1 in SMC hyperplasia was addressed in human cells and in an aortic-banding rat model of PH-LHD by analysing YAP1 activation and the effect of YAP1 inhibition. PA of LHD w/o PH and PH-LHD patients showed extensive remodelling of the BM. This was confirmed in vitro as altered composition and stiffening of dECM generated by respective patient endothelial cells. ECM remodelling was associated with SMC accumulation in the pulmonary arterial intima in patient samples and promoted SMC migration and proliferation in vitro. Conversely, dECM generated by healthy human endothelial cells reduced the hypermigration and hyperproliferation of SMC from LHD w/o PH and PH-LHD patients. Remodelling of the endothelial ECM in LHD w/o PH and PH-LHD patients also activated YAP1 in SMC, inhibition of which reduced SMC migration and proliferation in vitro. These findings were reproduced in vivo in a rat model of PH-LHD induced by aortic-banding. Conclusion: Here, we report endothelial ECM remodelling as a key mechanism driving SMC hyperplasia in PH-LHD. Notably, endothelial ECM remodelling is evident in both patients with LHD w/o PH and those with PH-LHD, raising the possibility that it may reflect an early event in LHD-induced pulmonary vascular remodelling. This ECM remodelling is associated with YAP1 in adjacent SMC, promoting their migration and proliferation and contributing to SMC hyperplasia. Consequently, targeting ECM remodelling and YAP1 activation may offer promising therapeutic strategies for preventing of PA remodelling in PH-LHD.

24 April 2025 in Cardiovascular Research
Verified
Journal Article
Closed access
MKMariya M Kucherenko
Mariya M Kucherenko
MKMarian Kukucka
Marian Kukucka
PSPengchao Sang
Pengchao Sang
NHNiklas Hegemann
Niklas Hegemann
QLQiuhua Li
Qiuhua Li
CKChristoph Knosalla
Christoph Knosalla
Aims: Pulmonary hypertension (PH) is a common complication of left heart disease (LHD) that leads to right heart failure and death. Pulmonary artery (PA) stiffening has recently emerged as an important diagnostic and prognostic parameter in PH. The present study aimed to develop and validate an ultrasonographic index to identify PA stiffening in PH due to LHD. Methods and results: First, ultrasonographic stiffness index (US-SI) was derived from pulmonary arterial (PA) radial strain (PA-RS), diameter, and stroke volume in rat model and correlated with ex vivo measured ‘true’ PA stiffness E. Then, US-SI was validated in a cohort of 24 LHD patients with or without PH prior to heart transplantation and again compared with ‘true’ PA stiffness measured ex vivo in collected PA specimens. In rats, ultrasonographic PA-RS and US-SI correlated closely with E, and both were able to detect ‘true’ PA stiffening with ≥80% sensitivity and specificity. In LHD patients, even though ultrasonographic right PA radial strain or US-SI correlated similarly with E, observer assessment and testing for diagnostic validity identified US-SI as more robust and accurate method that detects ‘true’ PA stiffening with 83.3% sensitivity and 95.8% specificity. Conclusions: Both PA strain and US-SI allow for ultrasonographic detection of PA stiffening in patients or animal models with LHD; however, US-SI identifies patients with stiffened PA with higher diagnostic validity and accuracy.

9 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
CKCeren Kocana
Ceren Kocana
LJLara Jaeschke
Lara Jaeschke
ACAlexandra Maria Chitroceanu
Alexandra Maria Chitroceanu
QZQi Zhang
Qi Zhang
NHNiklas Hegemann
Niklas Hegemann
WKWolfgang Kuebler
Wolfgang Kuebler
Background: Dyspnea and exercise intolerance are the primary clinical symptoms of heart failure. Heart failure patients experience frequent hypoxemic episodes, yet underlying mechanisms and relevance remain poorly understood. In a cohort of heart failure patients and multiple animal models, we identify pulmonary capillary rarefaction driven by excessive autophagy in endothelial cells as a novel mechanism of hypoxemia and cardiac disease progression. Methods: A cohort of heart failure with preserved ejection fraction (HFpEF) patients was analyzed for parameters of left ventricular (LV) dysfunction and pulmonary gas exchange. Morphological and cellular mechanisms of impaired pulmonary oxygenation were assessed in three animal models of heart failure, namely two HFpEF models, SU5416-treated ZSF1 obese rats and high fat diet/L-NAME treated mice, and in rats subjected to aortic banding. Lung microvascular rarefaction was quantified by micro-computed tomography, stereology, flow cytometry and dye efflux. Cellular mechanisms of capillary loss were analyzed by single-cell transcriptomics, electron microscopy and immunofluorescence, and in mice with endothelial-specific deletion of the autophagy gene Atg7 (Atg7 EN-KO ) . Results: In 234 HFpEF patients, advancing NYHA class was associated with progressive worsening of arterial oxygen saturation at rest and during exercise and a reduced lung diffusing capacity. Impaired gas diffusion correlated with indices of LV diastolic dysfunction. Impaired oxygenation and reduced exercise capacity were similarly evident in animal models of left heart disease, which showed a distinct loss of pulmonary microvessels and capillaries. Lung microvascular endothelial cells in HFpEF showed characteristics of increased autophagic flux and apoptosis. Relative to their wild type HFpEF controls, Atg7 EN-KO mice had less capillary loss, restored normoxemia, improved exercise tolerance, and mitigated LV diastolic dysfunction. Additional studies in HFpEF mice corroborated the functional relevance of impaired gas exchange for the progression of left heart disease by demonstrating that additional hypoxia aggravated, whereas moderate hyperoxia improved LV function. Conclusion: Our findings identify pulmonary microvascular rarefaction as a novel pathomechanism in heart failure that i) contributes to dyspnea and exercise intolerance, ii) impairs pulmonary gas exchange and iii) accelerates LV disease progression. Strategies targeting this axis such as moderate oxygen therapy may mitigate cardiopulmonary morbidity in heart failure. Clinical Trial Registration: Registered in the DRKS (Deutsches Register für klinische Studien) as trial# DRKS00032974 at https://drks.de/search/en/trial/DRKS00032974 .

9 September 2023 in European Respiratory Journal
Verified
Conference Paper
Closed access
MKMariya Kucherenko
Mariya Kucherenko
NVNetra Nambiar Veetil
Netra Nambiar Veetil
TGTara Gransar
Tara Gransar
SLShao-Fei Liu
Shao-Fei Liu
RSRobert Szulcek
Robert Szulcek
WKWolfgang M. Kuebler
Wolfgang M. Kuebler
PH-LHD is aggravated by pulmonary artery (PA) remodeling, the pathomechanism of which is poorly characterized. We identified SMC hyperplasia as a hallmark of PA remodeling in PH-LHD. In vitro evaluation of human primary PA SMCs revealed increased cell migration in both LHD patients’ prior to PH development (LHD w/o PH) and those from PH-LHD patients, with the latter also being characterized by increased proliferation, as compared to control SMCs. By electron microscopy, we identified the widening of endothelial BM in LHD w/o PH PAs and deterioration in PH-LHD. Mass spectrometry and atomic force microscopy assessments of decellularized ECM produced by endothelial cells (ECs) revealed enrichment in fibrillar collagens and increased stiffness in LHD w/o PH and PH-LHD, as compared to healthy EC ECM. As such, we hypothesized that remodeled and stiffened endothelial BM may trigger SMC hyperplasia by increasing cell migration and proliferation. Indeed, culturing of control SMCs on decellularized LHD w/o PH or PH-LHD endothelial ECM increased their proliferation and migration rates, while culturing of PH-LHD SMCs on decellularized control endothelial ECM inhibited these functions. Further in vitro analyses identified the involvement of the mechanosensitive YAP-1 in BM-to-SMC communication. Inhibition of Yap-1 by Verteporfin in a preclinical rat model of PH-LHD following aortic banding, reduced migration, and proliferation rates in isolated primary PA SMCs, and prevented PH, presenting a promising approach in the treatment of PH-LHD.